MZL facts Flashcards
gastric MALT % with HP
66%
BM involvement in MALT
< 10%
no need for BMB
POD24 in MALT
inferior OS
increased risk of transformation
MLT-IPI
age>70
LDH
Stage III/IV
HP eradication in gastric MALT
70% CR
Tests after eradication of HP
Confirm eradication 6 weeks after Tx, and 2 weeks after PPI discontinuation
Repeat endoscopy 3 mon after eradication
Timing of endoscopic FU after eradication of HP in gastric MALT
Not sooner than 3 months after eradication
Then every 3 months for 12 months
Define disease progression only after 12 months,
pts predicted to not respond to eradication in gastric MALT
t(11:18)
HP negative
Tx with RT
Tx of ocular MALT
Doxycycline 6 months- pulsatile
50-75% ORR
RT dosage for ocular MALT
4 Gy
in order to reduce catarct
Ocular MALT pathogen
C. psittaci
Bronchial MALT Tx
Surgical resection
RT for remaining lympoma
RX4 for no resectable tumors
Dural EMZL
More common than DLBCL of dura
usually diagnosed after resection
Tx choice is RT if not already resected
Colonic EMZL
rare
usually polypectomy is enough
Thyroid EMZL
Rare
usually due to autoimmune thyroiditis
resection is possible
Salivary gland EMZL
rare
due to sjogren
surgery is possible
Primary cutaneous MZL
Burellia burgerdofi
Good prognosis
RT
1st line Tx of advanced NMZL
BR X 4
R main in Adavnced NMZL
Better PFS with no OS benefit
More toxicity
Not approved
Nodal MZL %
10% of MZL
Association of nodal MZL
HCV
Eradication leads to lymphoma
Regression in the majority of patients
IgM paraprotein in nodal MZL %
10%
confuses with WM
Mutation specific for NMZL
PTPRD
SMZL %
20% of MZL